Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dependence on linkers' flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents. | J Enzyme Inhib Med Chem | 2022 | 36210545 | PubTator, text mining | PubMed |
| Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX. | Sci Rep | 2022 | 36202955 | PubTator, text mining | PubMed |
| Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. | Oncogene | 2022 | 36198774 | PubTator, text mining | PubMed |
| Roles of activator protein-2 gamma in breast cancer: A narrative review (SANRA). | Medicine (Baltimore) | 2022 | 36197225 | PubTator, text mining | PubMed |
| Identification and Validation of Three-Gene Signature in Lung Squamous Cell Carcinoma by Integrated Transcriptome and Methylation Analysis. | J Oncol | 2022 | 36193204 | PubTator, text mining | PubMed |
| Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease. | Clin Transl Immunology | 2022 | 36188122 | PubTator, text mining | PubMed |
| Clinical review of alkalization therapy in cancer treatment. | Front Oncol | 2022 | 36185175 | PubTator, text mining | PubMed |
| Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer. | Med Oncol | 2022 | 36175803 | PubTator, text mining | PubMed |
| Design and synthesis of some new benzoylthioureido phenyl derivatives targeting carbonic anhydrase enzymes. | J Enzyme Inhib Med Chem | 2022 | 36168122 | PubTator, text mining | PubMed |
| New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling. | Pharmaceuticals (Basel) | 2022 | 36145355 | PubTator, text mining | PubMed |
| Suppressing the PI3K/AKT Pathway by miR-30d-5p Mimic Sensitizes Ovarian Cancer Cells to Cell Death Induced by High-Dose Estrogen. | Biomedicines | 2022 | 36140161 | PubTator, text mining | PubMed |
| Development of Hydrogen Sulfide-Releasing Carbonic Anhydrases IX- and XII-Selective Inhibitors with Enhanced Antihyperalgesic Action in a Rat Model of Arthritis. | J Med Chem | 2022 | 36121705 | PubTator, text mining | PubMed |
| Expression and prognosis analysis of PAQR5 in kidney cancer. | Front Oncol | 2022 | 36119517 | PubTator, text mining | PubMed |
| Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host. | Comput Biol Med | 2022 | 36103744 | PubTator, text mining | PubMed |
| Prolonged, Low-Level Exposure to the Marine Toxin, Domoic Acid, and Measures of Neurotoxicity in Nonhuman Primates. | Environ Health Perspect | 2022 | 36102641 | PubTator, text mining | PubMed |
| Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia. | Sci Rep | 2022 | 36100684 | PubTator, text mining | PubMed |
| Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII. | Front Pharmacol | 2022 | 36091779 | PubTator, text mining | PubMed |
| Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity. | Molecules | 2022 | 36080139 | PubTator, text mining | PubMed |
| Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin. | Int J Mol Sci | 2022 | 36077298 | PubTator, text mining | PubMed |
| Novel 2-substituted thioquinazoline-benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity. | Arch Pharm (Weinheim) | 2022 | 36056903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=17